ABILIFY LAWSUITS FILED ON JULY 25, 2016
Presently, Abilify lawsuits filed against Bristol-Myers Squibb and Otsuka allege that the uncontrollable, compulsive behaviors were known prior to the 2016 label change. One lawsuit filed on July 25, 2016, in the United States District Court for the District of Massachusetts, states that the European Medicines Agency required Otsuka to warn patients and the medical community in Europe that the use of Abilify includes the risk of pathological gambling. Also, the European label includes additional language under the “Undesirable effects” section stating “Psychiatric disorders: agitation, nervousness, pathological gambling, suicide attempt, suicidal ideation and completed suicide.”
If you or a loved one has taken Abilify and struggled with uncontrollable behavior like compulsive gambling and binge eating or if you have amassed a gambling debt due to an uncontrollable urge to gamble, you may have the option to participate in a lawsuit against Bristol-Myers Squibb and Otsuka Pharmaceutical Company. Contact us today to learn more about your legal rights. There is never a fee unless we collect for you.